Abstract
The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD, MDMA, and ayahuasca, in the treatment of various psychiatric illnesses, such as treatment-resistant depression, post-traumatic stress disorder, end-of-life anxiety, and substance use disorders. There will also be a discussion of the safety and effectiveness as reported from both human and animal studies. Research has shown that psychedelics have the potential to become ground-breaking treatments for mental health disorders that are resistant to traditional therapies.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
